What happened
Adbiotech updated the terms of convertible bonds to raise $4M (₩6B), about 11.4% of its market value.
For context, this raise equals about 11.4% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | $4M (₩6B) |
| vs. market value | 11.4% |
| Filed | 2026-09-03, [기재정정]주요사항보고서(전환사채권발행결정) |
| Source | DART rcept 20260903000385 → open original filing |
Source: DART. Information only, not investment advice.